We are live on ! Find out more
BNP Paribas Financial Markets

BNP Paribas Financial Markets Portfolio holdings

AUM $289B
1-Year Est. Return 60.46%
 

BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.

This Fund
S&P 500
This Quarter Est. Return
+0.55%
1 Year Est. Return
+60.46%
3 Year Est. Return
+148.24%
5 Year Est. Return
+163.86%
10 Year Est. Return
+570.16%
AUM
$35.8B
AUM Growth
-$291M
Cap. Flow
+$190M
Cap. Flow %
0.53%
Top 10 Hldgs %
42.34%
Holding
3,782
New
210
Increased
2,320
Reduced
874
Closed
237

Sector Composition

Rank Sector Weight
1 Technology 10.27%
2 Financials 8.4%
3 Industrials 5.97%
4 Consumer Discretionary 5.96%
5 Healthcare 5.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GBNK
3001
DELISTED
Guaranty Bancorp
GBNK
$20.4K ﹤0.01%
1,233
+880
+249% +$14.5K
VSTM icon
3002
Verastem
VSTM
$604M
$20.3K ﹤0.01%
224
+193
+623% +$20.4K
CECO icon
3003
Ceco Environmental
CECO
$4.5B
$20.2K ﹤0.01%
1,786
+1,303
+270% +$14.8K
NAVB
3004
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$20.2K ﹤0.01%
627
+446
+246% +$13K
GEN
3005
DELISTED
Genesis Healthcare, Inc.
GEN
$20.1K ﹤0.01%
3,049
+2,507
+463% +$16.9K
APEX
3006
DELISTED
Apex Global Brands Inc. Common Stock
APEX
$20.1K ﹤0.01%
+24
New +$16.7K
BOX icon
3007
Box
BOX
$4.66B
$20K ﹤0.01%
1,075
+779
+263% +$13.7K
PFSI icon
3008
PennyMac Financial
PFSI
$4.13B
$20K ﹤0.01%
1,102
+785
+248% +$14.3K
IAG icon
3009
IAMGOLD
IAG
$10.1B
$19.9K ﹤0.01%
9,974
EGIO
3010
DELISTED
Edgio, Inc. Common Stock
EGIO
$19.9K ﹤0.01%
127
+92
+263% +$14.5K
CRD.B icon
3011
Crawford & Co Class B
CRD.B
$585M
$19.9K ﹤0.01%
2,366
+1,711
+261% +$13.9K
UNTD
3012
DELISTED
UNITED ONLINE INC COM NEW
UNTD
$19.9K ﹤0.01%
1,271
-12,386
-91% -$205K
BRG
3013
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
$19.9K ﹤0.01%
+1,568
New +$21.1K
LGTY
3014
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
$19.7K ﹤0.01%
2,073
+1,500
+262% +$14.4K
SNMX
3015
DELISTED
Senomyx, Inc.
SNMX
$19.5K ﹤0.01%
3,645
+2,649
+266% +$14.1K
TPLM
3016
DELISTED
Triangle Petroleum Corporation
TPLM
$19.5K ﹤0.01%
3,879
+2,291
+144% +$12.3K
ZAGG
3017
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
$19.5K ﹤0.01%
+2,457
New +$22K
SEAC
3018
DELISTED
Seachange International Inc
SEAC
$19.4K ﹤0.01%
139
+100
+256% +$14.1K
IMDZ
3019
DELISTED
Immune Design Corp.
IMDZ
$19.4K ﹤0.01%
941
+799
+563% +$18.9K
ATLO icon
3020
AMES National
ATLO
$281M
$19.4K ﹤0.01%
774
+577
+293% +$14.4K
GBLI icon
3021
Global Indemnity Group
GBLI
$413M
$19.4K ﹤0.01%
691
+498
+258% +$13.9K
CYTK icon
3022
Cytokinetics
CYTK
$10.2B
$19.4K ﹤0.01%
2,886
+2,066
+252% +$13.5K
REI icon
3023
Ring Energy
REI
$349M
$19.3K ﹤0.01%
1,725
+1,236
+253% +$14.5K
LQDT icon
3024
Liquidity Services
LQDT
$1.35B
$19.3K ﹤0.01%
2,004
+1,413
+239% +$13.9K
FOMX
3025
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$19.3K ﹤0.01%
+1,882
New +$20.8K

Similar funds

BNP Paribas Financial Markets's Q2 2015 Portfolio in Review

As of Q2 2015, BNP Paribas Financial Markets held 3,782 positions worth $35.8B, down 0.81% from $36.1B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

BNP Paribas Financial Markets's Q2 2015 filing shows 210 new, 2,320 increased, 874 reduced and 237 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 300,000 shares worth $56.7M. The largest sale was Apple, an estimated $949M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 14% a quarter earlier, followed by Financials and Industrials.

  • BNP Paribas Financial Markets's largest Q2 2015 buy was Vanguard S&P 500 ETF: 300,000 shares worth $56.7M.
  • BNP Paribas Financial Markets added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $2.01B increase.
  • BNP Paribas Financial Markets's biggest Q2 2015 reduction was Apple, cutting an estimated $949M.
  • BNP Paribas Financial Markets fully exited Allergan plc in Q2 2015, selling an estimated $55.7M.
  • BNP Paribas Financial Markets's ten largest holdings make up 42% of its $35.8B portfolio in Q2 2015.
  • BNP Paribas Financial Markets opened 210 new positions and closed 237 in Q2 2015.
  • BNP Paribas Financial Markets's portfolio value fell 0.81% quarter-over-quarter to $35.8B.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2015, filed 14 Aug 2015.